Exelixis Clinical #4 — Pittsburgh, Pennsylvania

Exelixis Clinical #4 is a clinical research site located in Pittsburgh, Pennsylvania, United States 15224.

Crixeo Health Trust Score: 48/100 (POOR). This profile has not yet been claimed by the site owner.

Exelixis Clinical #4 has participated in 1 clinical trials.

Therapeutic areas: Non-Hodgkin's Lymphoma (NHL), Activated B-Cell Type Diffuse Large B-Cell Lymphoma (ABC-DLBCL), Mantle Cell Lymphoma (MCL).

Sponsors: Exelixis.

Sponsor Feasibility Report

Trust Score: 48/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Exelixis Clinical #4?

Exelixis Clinical #4 has a Crixeo Trust Score of 48/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Exelixis Clinical #4 conducted?

Exelixis Clinical #4 has 1 clinical trials on record. Their work covers Non-Hodgkin's Lymphoma (NHL), Activated B-Cell Type Diffuse Large B-Cell Lymphoma (ABC-DLBCL), Mantle Cell Lymphoma (MCL).

Is Exelixis Clinical #4 accredited by Crixeo Health?

Exelixis Clinical #4 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Exelixis Clinical #4?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.